US sinks another $2.1 billion into a potential vaccine

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental Covid-19 vaccine to the United States as governments buy up supplies in hopes something will work. ​US will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement. Sanofi will get the bulk of the funds.